We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$33.6B
AUM Growth
+$1.17B
(+3.6%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
81
New
10
Increased
30
Reduced
38
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$378M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$222M |
| 3 |
Okta
OKTA
|
+$210M |
| 4 |
BLUE
bluebird bio
BLUE
|
+$148M |
| 5 |
Zoom
ZM
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$360M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$338M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$328M |
| 4 |
Shopify
SHOP
|
+$268M |
| 5 |
Atlassian
TEAM
|
+$64.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Consumer Discretionary | 20.96% |
| 3 | Healthcare | 20.88% |
| 4 | Communication Services | 16.1% |
| 5 | Financials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aptiv
APTV
$12.4B
| $415M | 1.24% |
5,137,999
+107,249
| +2% | +$8.49M |
|
|
LKFT
27
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $363M | 1.08% |
2,813,309
-68,951
| -2% | -$8.18M |
|
28
Incyte
INCY
$25.3B
| $360M | 1.07% |
4,235,373
-105,422
| -2% | -$8.46M |
|
29
Floor & Decor
FND
$6B
| $345M | 1.03% |
8,236,822
-221,494
| -3% | -$9.26M |
|
30
Alphabet (Google) Class C
GOOG
$4.1T
| $329M | 0.98% |
6,094,000
-157,340
| -3% | -$9.08M |
|
|
31
Regeneron Pharmaceuticals
REGN
$73.1B
| $304M | 0.9% |
971,166
-1,016,547
| -51% | -$338M |
|
|
SCHW
32
Charles Schwab
SCHW
$185B
| $279M | 0.83% |
6,929,970
-156,997
| -2% | -$6.84M |
|
33
Palo Alto Networks
PANW
$256B
| $277M | 0.82% |
8,158,392
-184,560
| -2% | -$6.9M |
|
34
Twilio
TWLO
$28.8B
| $276M | 0.82% |
2,026,404
-37,804
| -2% | -$5.03M |
|
|
ATVI
35
DELISTED
Activision Blizzard
ATVI
| $265M | 0.79% |
5,623,477
-154,552
| -3% | -$7.1M |
|
36
Las Vegas Sands
LVS
$32B
| $243M | 0.72% |
4,108,350
-103,866
| -2% | -$6.43M |
|
|
37
Okta
OKTA
$23.6B
| $239M | 0.71% |
+1,938,689
| New | +$210M |
|
|
NBIS
38
Nebius Group N.V.
NBIS
$39.5B
| $201M | 0.6% |
5,285,206
+281,400
| +6% | +$10.4M |
|
39
Mercado Libre
MELI
$94.5B
| $199M | 0.59% |
324,738
+19,240
| +6% | +$10.7M |
|
40
Sea Limited
SE
$65.9B
| $150M | 0.45% |
4,505,500
+1,009,135
| +29% | +$27.4M |
|
|
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $142M | 0.42% |
+1,379,614
| New | +$107M |
|
|
BLUE
42
DELISTED
bluebird bio
BLUE
| $141M | 0.42% |
+85,579
| New | +$148M |
|
43
TSMC
TSM
$1.96T
| $137M | 0.41% |
3,502,420
+395,565
| +13% | +$16.3M |
|
44
Trip.com Group
TCOM
$29.2B
| $136M | 0.41% |
3,695,572
+185,650
| +5% | +$7.32M |
|
|
45
Zoom
ZM
$27.1B
| $135M | 0.4% |
+1,518,198
| New | +$125M |
|
46
HDFC Bank
HDB
$122B
| $105M | 0.31% |
3,234,176
+428,908
| +15% | +$12.9M |
|
47
New Oriental
EDU
$9.2B
| $99.7M | 0.3% |
1,032,767
+262,523
| +34% | +$23.5M |
|
48
Grupo Aeroportuario del Sureste
ASR
$8.23B
| $78.8M | 0.23% |
486,173
+28,518
| +6% | +$4.66M |
|
49
MakeMyTrip
MMYT
$5.33B
| $69.8M | 0.21% |
2,813,264
+190,512
| +7% | +$4.82M |
|
50
Baidu
BIDU
$35.7B
| $60.3M | 0.18% |
513,570
+30,519
| +6% | +$4.35M |
|
Similar funds
KK
VAI
UIM
SO
Sands Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Sands Capital Management held 81 positions worth $33.6B, up 3.6% from $32.4B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sands Capital Management's Q2 2019 filing shows 10 new, 30 increased, 38 reduced and 2 closed positions. Its largest new stake was Okta: 1,938,689 shares worth $239M. The largest sale was Booking.com, an estimated $360M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sands Capital Management's largest Q2 2019 buy was Okta: 1,938,689 shares worth $239M.
- Sands Capital Management added most to Zoetis in Q2 2019, an estimated $378M increase.
- Sands Capital Management's biggest Q2 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $338M.
- Sands Capital Management fully exited Booking.com in Q2 2019, selling an estimated $360M.
- Sands Capital Management's ten largest holdings make up 52% of its $33.6B portfolio in Q2 2019.
- Sands Capital Management opened 10 new positions and closed 2 in Q2 2019.
- Sands Capital Management's portfolio value rose 3.6% quarter-over-quarter to $33.6B.
Based on Sands Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.